Forlaks powder for solution for children inside 4d pack. 20 pc

$5.64

Forlaks powder for solution for children inside 4d pack. 20 pc

Quantity:

SKU: 091256918 Categories: , , Tag:

Description

Composition
Active substance:
Macrogol 4000 (polyethylene glycol 4000) 4000,0.
Excipients:
Perfume with the scent of orange and grapefruit * 60.0
Sodium saccharinate 6.8 * Orange oil, grapefruit oil, orange juice concentrate, citral, acetaldehyde, linalol, ethyl butyrate, alpha terpineol, octanal, cis-3-hexenol, maltodextrin, acacia gum, sorbitol.
Description:
The powder is white or almost white smell from orange and grapefruit, readily soluble in water to form a white translucent solution.
Product form:
Powder for solution for oral administration (for children) 4 g
By 4.0668 g in single-dose sachets made of paper laminated with aluminum foil and polyethylene. 20 bags were placed together with instructions for use in a cardboard pack.
Contraindications
– severe inflammatory bowel disease (ulcerative colitis, Crohn’s disease) or toxic megacolon; – the risk of perforation or perforation of the intestine; – full or partial bowel obstruction and suspected bowel obstruction, symptomatic stenosis; – abdominal pain of unknown etiology; – hypersensitivity to macrogol (polyethylene glycol), or other components of the preparation.
Dosage
4 g
Indications
Symptomatic treatment of constipation in children aged 6 months to 8 years.
Interaction with other drugs
Delays absorption concomitant drugs.
Therefore, it is recommended to appoint Forlaks® later, at least 2 hours after the administration of other drugs.
Overdose
An overdose of the drug leads to diarrhea, followed by the disappearance after dose reduction or treatment discontinuation.
Intense diarrhea or vomiting may cause disruption vvodnoelektrolitnogo balance, which will require its correction.
There are reports of occurrence of inflammation and irritation of the perianal region and anal incontinence in cases of the use of polyethylene glycol in large volumes (4 – 11 liters) in order to clean the bowel prior to colonoscopy.
pharmachologic effect
Pharmacological group:
Laxative.
Pharmacodynamics:
Large molecular weight of macrogol 4000 due to the long linear polymers which retain water molecules by means of hydrogen bonds.
Due to this, after oral administration increases the amount of intestinal contents.
The volume of unabsorbed fluid in the lumen of the intestine, supports a laxative effect solution.
Pharmacokinetics:
The pharmacokinetic data confirm that macrogol 4000 is not subject to any gastrointestinal resorption nor biotransformation after oral administration.
Pregnancy and breast-feeding
Not applicable.
Conditions of supply of pharmacies
Without a prescription.
side effects
of adverse reactions Data are presented in accordance with the following classification: very often (> 1/10), often (> 1/100 –
special instructions
PRECAUTIONS FOR USE
Organic disorders of the gastrointestinal tract should be excluded prior to initiating therapy.
Warning.
constipation treatment with drugs recommended only as an aid to healthy lifestyle and diet, for example: – increase in fluid and fiber consumption, – adequate physical activity that contributes to the restoration of gastrointestinal motility.
If constipation symptoms persist for more than 3 months, it is necessary to re advanced diagnostic testing.
In the case of diarrhea with extreme caution should treat patients prone to disruption of water-electrolyte balance (e.g., in patients with impaired hepatic or renal function or patients taking diuretics) and electrolyte control should be carried out.
Forlaks® not contain substantial amounts of carbohydrate and / or polyols (sugar alcohols) and can be used in patients with diabetes or in patients who are excluded from the diet galactose.
It has been reported very rare cases of hypersensitivity (including rash, hives, swelling) upon receipt of preparations containing macrogol (polyethylene glycol). In exceptional cases, anaphylactic shock was observed.
Because of the presence of sorbitol, patients with congenital fructose intolerance should not take this drug.
It reported cases of aspiration, when a large amount of macrogol and electrolytes administered via a nasogastric tube.
Children with neurological disorders that have a swallowing disorder are at risk of aspiration.
IMPACT ON drive vehicles and management mechanisms
No data available.
Storage conditions
At a temperature of not higher than 30 ° C.
Keep out of the reach of children.
Dosing and Administration
Inside. – from 6 months to 1 year: 1 sachet per day. – 1 to 4 years: 1 to 2 sachets per day. – from 4 to 8 years: from 2 to 4 bags per day.
The contents of one sachet should be dissolved in about 50 ml of water and taken in the morning (when the dosage – 1 sachet per day) or take the morning and evening (if the dosage is – more than 1 sachet per day).
Duration of treatment – no more than 3 months.
Action manifests Forlaksa® after 24 – 48 hours after administration.
Maintenance of effect after the restoration of normal functioning of the intestines should be carried out with the help of an active lifestyle and a diet rich in plant fiber.
If constipation symptoms persist for more than 3 months, it is necessary to re extended diagnostic tests.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

Ipsen

There are no reviews yet.

Add your review